C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2004
11/18/2004	WO2004099236A1 A process for the preparation of perindopril using tetramethyluronium salts as coupling reagents
11/18/2004	WO2004099193A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof
11/18/2004	WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099170A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099168A2 Substituted carboxylic acids
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099141A1 A novel process for preparation of indole derivatives
11/18/2004	WO2004099140A1 Novel crystalline forms of sumatriptan succinate
11/18/2004	WO2004099139A1 Indole-containing compounds with anti-tubulin and vascular targeting activity
11/18/2004	WO2004099138A2 Process for the preparation of perindopril
11/18/2004	WO2004099129A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004	WO2004069998A3 Oxindole derivatives as antimicrobial agents
11/18/2004	WO2004043350A3 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING
11/18/2004	US20040229958 Synthesis of N-methyl-N-phenylaminoacrolein
11/18/2004	US20040229952 a thiohydrazide product compound prepared by reacting a hydrazide starting compound with a thionylating reagent; anticancer agents
11/18/2004	US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004	US20040229931 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229904 Compounds useful for the treatment of diseases
11/18/2004	US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229865 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2524927A1 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	CA2524235A1 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/17/2004	EP1477544A2 Blue Light-emitting Compounds, Blue Light-emitting Polymers, Processes of Preparing the Blue Light-emitting Compounds and Luminescent Element Including the Blue Light-emitting Polymers
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477475A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
11/17/2004	EP1477474A1 Process for the synthesis of N-methyl-N-phenylaminoacrolein
11/17/2004	EP1477472A1 Substituted phenylalkanoic acid derivative and use thereof
11/17/2004	EP1476787A1 Visible radiation sensitive composition
11/17/2004	EP1476426A2 Hydroxylated indirubin derivatives
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1476149A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004	EP1319006B1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1075471B1 Indolyl derivatives as serotonergic agents
11/17/2004	CN1546446A Fluorene derivatives and their application
11/17/2004	CN1176077C Tegaserod maleate-water crystal
11/16/2004	US6818788 Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818023 Colorants
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004096802A2 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004096768A1 Anti-diabetic agents
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096766A1 A method of indole synthesis
11/11/2004	WO2004096765A2 A novel crystalline polymorph of fluvastatin sodium and a process for preparing it
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004080376A3 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	WO2003064433A8 Polymerization catalyst activator and its use in a polymerization process
11/11/2004	US20040225132 Carvedilol
11/11/2004	US20040225124 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040225002 Derivatives of isoindigo, indigo and indirubin and methods of treating cancer
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224972 Medicinal compositions for concomitant use as anticancer agent
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040223913 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/11/2004	CA2524125A1 Antibiotic tetrahydro-.beta.-carboline derivatives
11/11/2004	CA2523102A1 Substituted indoline and indole derivatives
11/11/2004	CA2521962A1 Anti-diabetic agents
11/10/2004	EP1475398A1 Indole resins, epoxy resins and resin compositions containing the same
11/10/2004	EP1475379A1 Use of scopine ester derivatives for the synthesis of drugs
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474390A1 Indole derivatives substituted with long-chain alcohols and medicaments containing them
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474133A2 Crystalline solids of carvedilol and processes for their preparation
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP0800831B9 Diagnostic marker
11/10/2004	CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004	CN1545502A Process for the preparation of indole derivatives
11/10/2004	CN1544419A N-substituted indole derivative preparation method
11/10/2004	CN1174969C New preparation method for N-(1, 1-dimethyl ethide)-4-[[(5'-oxethyl-4-cis-[2-(4-morpholino) oxethyl]-2'-oxo ancylus [cyclohexane-1, 3'-[3H] indole]-1'(2'H) group)-sulfonyl]-3-methoxyl benzamide and it

1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 458